AI assistant
Sending…
Inogen Inc — Director's Dealing 2021
Jun 22, 2021
33625_dirs_2021-06-21_17264279-987e-4c0c-91df-11f2296efd65.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2021-06-21
Reporting Person: Glezer Stanislav (EVP, Chief Medical Officer)
More from Inogen Inc
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 27